Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 3—March 2017
Research

Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis

Colleen ScottComments to Author , Joseph S. Cavanaugh, Benjamin J. Silk, Julia Ershova, Gerald H. Mazurek, Philip A. LoBue, and Patrick K. Moonan
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 1

Selection of tuberculosis cases for analysis of sputum-culture conversion, United States, 2006–2013. Analysis included cases of culture-negative disease. A total of 61% of case-patients with M. bovis TB and 63% of case-patients with M. tuberculosis TB met analytic requirements for inclusion. PZA, pyrazinamide; TB, tuberculosis. *Includes patients with culture-negative disease. †Mycobacterium tuberculosis with pyrazinamide resistance (n = 757).

Figure 1. Selection of tuberculosis cases for analysis of sputum-culture conversion, United States, 2006–2013. Analysis included cases of culture-positive disease. A total of 61% of case-patients with M. bovis TB and 63% of case-patients with M. tuberculosis TB met analytic requirements for inclusion. PZA, pyrazinamide; TB, tuberculosis. Mycobacterium tuberculosis with pyrazinamide resistance (n = 757).

Main Article

Page created: February 17, 2017
Page updated: February 17, 2017
Page reviewed: February 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external